9.690CAD-0.31%Mkt Cap: 692.84M $P/E: 161.501d ago
Knight Therapeutics Inc. focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America. The company offers Minjuvi for relapsed or refr…
Industry Peers
Drug Manufacturers - Specialty & Generic$65.19BUSDP/E 23.7
$22.46BUSDP/E 19.5
$20.18BUSD
$17.25BUSDP/E 26.4
$15.47BUSDP/E 179.2
$14.18BUSDP/E 29.7
$12.96BUSD
$8.93BUSDP/E 22.7
$7.80BUSD
$6.84BUSDP/E 25.1
$6.69BUSDP/E 442.8
$5.76BUSDP/E 48.8
$3.65BUSDP/E 19.0
$3.55BUSDP/E 11.3
$2.99BUSDP/E 20.9
$2.80BUSD
$2.52BUSDP/E 56.0
$2.35BUSDP/E 16.3
$2.40BUSDP/E 12.9
$2.31BUSD
$1.92BUSDP/E 19.4
$1.89BUSD
$1.86BUSDP/E 21.0
$1.71BUSD
$1.89BUSD
$1.67BUSD
$1.48BUSDP/E 17.5
$1.50BUSDP/E 124.1
$1.40BUSDP/E 14.8
$1.12BUSDP/E 35.4
$1.18BUSDP/E 17.6
$1.23BUSD
$1.06BUSDP/E Infinity
$1.02BUSD
$1.01BUSDP/E 196.9
$985.07MUSD
$918.60MUSDP/E 14.7
$873.22MUSDP/E 38.1
$875.69MUSDP/E 12.0
$819.46MUSDP/E Infinity
$668.29MUSD
$637.05MUSDP/E 6.2
$505.77MUSDP/E 14.3
$494.34MUSD
$447.41MUSD
$427.80MUSD
$396.78MUSD
$375.56MUSD
$370.76MUSD
$355.90MUSD
$343.56MUSD
$357.30MUSD
$320.48MUSDP/E 43.7
$294.94MUSDP/E 15.2
$303.08MUSDP/E 9.7
$273.62MUSDP/E 49.1
$285.23MUSD
$250.29MUSDP/E 47.6
$255.34MUSDP/E 12.7
$236.39MUSDP/E 53.0
$206.95MUSDP/E 10.3
$210.49MUSD
$195.77MUSD
$185.67MUSD
$182.70MUSDP/E 8.8
$164.20MUSD
$143.26MUSDP/E 18.3
$146.07MUSD
$133.59MUSD
$126.10MUSD
$119.66MUSDP/E 18.6
$114.77MUSD
$83.73MUSDP/E 12.0
$94.75MUSD
$72.66MUSD
$67.25MUSD
$70.06MUSD
$62.42MUSDP/E 52.6
$63.44MUSDP/E 21.8
$60.48MUSD
$63.41MUSD
$53.86MUSD
$50.62MUSD
$49.37MUSD
$48.31MUSD
$42.20MUSD
$41.16MUSD
$33.86MUSDP/E Infinity
$31.75MUSD
$27.85MUSD
$26.87MUSD
$23.61MUSDP/E 204.0
$23.18MUSD
$22.62MUSD
$22.15MUSD
$18.56MUSD
$17.65MUSD
$14.93MUSD
$13.84MUSDP/E 16.8
$14.21MUSD
$11.64MUSD
$11.91MUSD
$9.88MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.05MUSDP/E 3.7
$6.17MUSD
$6.48MUSDP/E 0.3
$5.84MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$2.01MUSD
$1.93MUSD
$2.08MUSDP/E 35.5
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap692.84M $
Enterprise Value639.38M $
Revenue (TTM)371.74M $
Gross Profit145.82M $
Net Income (TTM)-3.91M $
Revenue/Share3.745 USD
Last Price9.690 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees830
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)161.50
P/E (Forward)37.27
PEG—
EV/EBITDA12.52
EV/Revenue1.72
P/S1.86
P/B1.21
EPS (TTM)0.06
EPS (Forward)0.26
52W Range
5.66089% of range10.17
52W High10.17 CAD
52W Low5.660 CAD
Profitability
Gross Margin44.49%
Oper. Margin7.13%
EBITDA Margin13.74%
Profit Margin-1.19%
ROE-0.70%
ROA-0.51%
Growth
Revenue Growth68.50%
Earnings Growth550.00%
Cash Flow & Leverage
Operating CF50.22M $
CapEx (TTM)24.54M $
FCF Margin13.01%
FCF Yield6.98%
Net Debt-53.46M $
Net Debt/EBITDA-1.05
Balance Sheet
Debt/Equity0.10
Current Ratio2.32
Quick Ratio1.56
Book Value/Sh8.013 CAD
Cash/Share1.458 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)9.829 CAD
Upside (mean)+1.4%
Target Range9.000 CAD – 12.00 CAD
CAD9.000+1.4% to meanCAD12.00
# Analysts7
Ownership
Shares Out.98.18M
Float60.24M
Insiders46.99%
Institutions18.13%
Short Interest
Short Ratio15.5d
Short % Out.1.44%
Shares Short1.62M
Short (prev mo.)1.73M
Technical
SMA 509.022 (+7.4%)
SMA 2006.989 (+38.6%)
Beta0.05
S&P 52W Chg19.63%
Avg Vol (30d)113.89K
Avg Vol (10d)137.02K
Technical Indicators
RSI (14)58.8
MACD0.2408
MACD Signal0.3030
MACD Hist.-0.0622
BB Upper10.23 CAD
BB Middle9.671 CAD
BB Lower9.114 CAD
BB Width11.52%
ATR (14)0.2355 CAD
Vol Ratio (20d)0.32x